Compound Detail
CHEMBL4297674
BRANEBRUTINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4297674 |
| Name | BRANEBRUTINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | VJPPLCNBDLZIFG-ZDUSSCGKSA-N |
10
Targets
34
Activities
3
Assay Types
30
PK Parameters
20
Publications
2
Known Names
3
Indications
1
Mechanisms
Molecular Properties
370.4
MW (Da)
2.13
ALogP
3
HBA
3
HBD
91.2
PSA (Ų)
0.72
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase BTK inhibitor | INHIBITOR | Tyrosine-protein kinase BTK | ✓ | ✓ |
Indications
Arthritis, Rheumatoid Autoimmune Diseases Hematologic Neoplasms
Activity Summary
IC50 27 meas. best 10.4
Kd 6 meas. best 9.25
Ki 1 meas. best 6.94
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| B cell CHEMBL5314312 | IC50 | 10.4 | 10.4 | 0.0 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 10.05 | 9.2461 | 0.1 | 18 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Kd | 9.25 | 9.25 | 0.6 | 1 |
| Tyrosine-protein kinase Tec CHEMBL4246 | IC50 | 9.05 | 9.005 | 0.9 | 2 |
| Tyrosine-protein kinase Tec CHEMBL4246 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX CHEMBL3834 | IC50 | 8.82 | 8.82 | 1.5 | 1 |
| Tyrosine-protein kinase TXK CHEMBL4367 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX CHEMBL3834 | Kd | 7.66 | 7.66 | 22.0 | 1 |
| Tyrosine-protein kinase ITK/TSK CHEMBL2959 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Ki | 6.94 | 6.94 | 116.0 | 1 |
| Tyrosine-protein kinase ITK/TSK CHEMBL2959 | Kd | 6.5 | 6.5 | 320.0 | 1 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | IC50 | 5.98 | 5.98 | 1040.0 | 1 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | Kd | 5.89 | 5.89 | 1300.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.7 | 5.7 | 2000.0 | 1 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | Kd | 5.6 | 5.6 | 2500.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 19262.36 | ng.hr.mL-1 | Mus musculus |
| AUC | 5186.02 | ng.hr.mL-1 | Mus musculus |
| AUC | 6667.74 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1815.11 | ng.hr.mL-1 | Macaca mulatta |
| AUC | 28893.54 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 14.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 8.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 9.4 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 0.94 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 42000.0 | nM | Mus musculus |
| Cmax | 7700.0 | nM | Mus musculus |
| Cmax | 9600.0 | nM | Rattus norvegicus |
| Cmax | 2300.0 | nM | Macaca mulatta |
| Cmax | 19000.0 | nM | Canis lupus familiaris |
| F | 106.0 | % | Mus musculus |
| F | 74.0 | % | Rattus norvegicus |
| F | 46.0 | % | Macaca mulatta |
| F | 81.0 | % | Canis lupus familiaris |
| MRT | 0.57 | hr | Mus musculus |
| MRT | 0.8 | hr | Rattus norvegicus |
| MRT | 1.0 | hr | Macaca mulatta |
| MRT | 4.1 | hr | Canis lupus familiaris |
| T1/2 | 0.46 | hr | Mus musculus |
| T1/2 | 4.3 | hr | Rattus norvegicus |
| T1/2 | 3.2 | hr | Macaca mulatta |
| T1/2 | 3.0 | hr | Canis lupus familiaris |
| Tmax | 1.0 | hr | Mus musculus |
| Tmax | 0.58 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Macaca mulatta |
| Tmax | 0.67 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine